4.32 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
Verastem, Inc.
VSTMNASDAQ • USD
4.38
↗ 0.06 (1.39%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
4.38
↗ 0.06 (1.39%)
Market: CLOSED
Open?$4.70
High?$4.75
Low?$4.30
Prev. Close?$4.32
Volume?2.2M
Avg. Volume?2.2M
VWAP?$4.44
Rel. Volume?1.01x
Bid / Ask
Bid?$4.36 × 100
Ask?$4.50 × 2.5K
Spread?$0.14
Midpoint?$4.43
Valuation & Ratios
Market Cap?379.6M
Shares Out?87.9M
Float?50.9M
Float %?76.3%
P/E Ratio?N/A
P/B Ratio?4.64
EPS?-$2.21
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Employees
102
Market Cap
379.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2012-01-27
Address
117 KENDRICK STREET
NEEDHAM, MA 02494
Phone: (781) 292-4200
NEEDHAM, MA 02494
Phone: (781) 292-4200
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.04Strong
Quick Ratio?3.00Strong
Cash Ratio?2.48Strong
Debt/Equity?1.01Moderate
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?4.64FAIR▾
P/S?7.66HIGH▾
P/FCF?N/A▾
EV/EBITDA?-1.8CHEAP▾
EV/Sales?5.98FAIR▾
Returns & Efficiency
ROE?-237.2%WEAK▾
ROA?-85.1%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$296.7M
Fundamentals ratios updated end of day